Research / DT / Fundamental state Inspectable configuration
State dimensions Filing 0001773383-22-000091 General Corporate
Debt relative to revenue 17th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.debt_to_revenue
91.45% · OPTIONAL · VALID
Capex intensity 58th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.58% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=12
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
53.54% · OPTIONAL · VALID
Revenue growth 13th Own-history percentile · N=8
Evidence method Yoy · gp.fundamentals.revenue
27.43% · CORE · VALID
Gross margin 33th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.gross_margin
80.62% · CORE · VALID
Operating margin 33th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.operating_margin
7.14% · CORE · VALID
R&D intensity 75th Own-history percentile · N=12
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
18.14% · OPTIONAL · VALID
SBC intensity 58th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
10.74% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 29 states Self-history eligible
Sep 30, 2021 7/8 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 29.47%
Current 91.45%
Delta 61.98% Capex Intensity Increased
Previous 1.90%
Current 2.58%
Delta 0.68% Cash Generation Increased
Previous 27.00%
Current 53.54%
Delta 26.54% Growth Decreased
Previous 32.12%
Current 27.43%
Delta -4.68% Margin Decreased
Previous 81.40%
Current 80.62%
Delta -0.78% Profitability Decreased
Previous 8.75%
Current 7.14%
Delta -1.60% R And D Intensity Increased
Previous 16.82%
Current 18.14%
Delta 1.32% Sbc Intensity Increased
Previous 10.71%
Current 10.74%
Delta 0.03% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.